Recombinant Vaccinia-gp100:209-217
A recombinant vaccinia virus encoding a modified peptide of the gp100 melanoma-melanocyte antigen with potential use in cancer immunotherapy. gp100 human antigen is a wild type self-antigen expressed by melanocytes, pigmented retinal cells and most melanomas. gp100p209 is a fragment epitope of gp100 in which the threonine in position 2 is replaced with methionine; this modification may stimulate tumor infiltrating lymphocytes (TIL) more efficiently. (NCI04)
Exact Synonyms
Recombinant Vaccinia-gp100:209-217
rV-gp100P209-217
rv-gp100P209
class Information
code
C29566
Legacy Concept Name
Recombinant_Vaccinia-gp100p209
Preferred_Name
Recombinant Vaccinia-gp100:209-217
Semantic_Type
Pharmacologic Substance
UMLS_CUI
C1514797